Home/Filings/4/0000899243-23-001100
4//SEC Filing

Newcomb George A. 4

Accession 0000899243-23-001100

CIK 0001932393other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:39 PM ET

Size

39.4 KB

Accession

0000899243-23-001100

Insider Transaction Report

Form 4
Period: 2023-01-03
Newcomb George A.
Chief Accounting Officer
Transactions
  • Award

    Common stock, par value $0.01 per share

    2023-01-03+1212 total(indirect: By family member)
  • Award

    Deferred Bonus Phantom Stock Units

    2023-01-03+2828 total
    Common stock, par value $0.01 per share (28 underlying)
  • Award

    Restricted Stock Units

    2023-01-04+2,5992,599 total
    Common stock, par value $0.01 per share (2,599 underlying)
  • Award

    Common stock, par value $0.01 per share

    2023-01-03+143143 total(indirect: By 401(k))
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+3,6723,672 total
    Exercise: $142.15Exp: 2024-09-05Common stock, par value $0.01 per share (3,672 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+3,6723,672 total
    Exercise: $135.92Exp: 2025-09-11Common stock, par value $0.01 per share (3,672 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+6,6386,638 total
    Exercise: $40.40Exp: 2028-12-21Common stock, par value $0.01 per share (6,638 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+6,8356,835 total
    Exercise: $57.74Exp: 2029-03-19Common stock, par value $0.01 per share (6,835 underlying)
  • Award

    Restricted Stock Units

    2023-01-04+1,2611,261 total
    Common stock, par value $0.01 per share (1,261 underlying)
  • Award

    Restricted Stock Units

    2023-01-04+2,5492,549 total
    Common stock, par value $0.01 per share (2,549 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+2,4342,434 total
    Exercise: $99.21Exp: 2027-11-17Common stock, par value $0.01 per share (2,434 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+3,2293,229 total
    Exercise: $51.67Exp: 2029-04-11Common stock, par value $0.01 per share (3,229 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+8,4168,416 total
    Exercise: $63.51Exp: 2030-03-02Common stock, par value $0.01 per share (8,416 underlying)
  • Award

    Common stock, par value $0.01 per share

    2023-01-03+439439 total
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+3,6723,672 total
    Exercise: $129.52Exp: 2023-09-13Common stock, par value $0.01 per share (3,672 underlying)
  • Award

    Employee Stock Option (right to buy)

    2023-01-04+4,5924,592 total
    Exercise: $161.30Exp: 2026-09-30Common stock, par value $0.01 per share (4,592 underlying)
Footnotes (9)
  • [F1]The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
  • [F2]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.
  • [F3]Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.
  • [F4]Each unit of phantom stock is the economic equivalent of one share of GE HealthCare common stock.
  • [F5]Award of phantom stock with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Payable after termination of service. This transaction is being reported notwithstanding the exemption provided by Rule 16a-9.
  • [F6]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
  • [F7]Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.
  • [F8]Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.
  • [F9]Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

Issuer

GE HealthCare Technologies Inc.

CIK 0001932393

Entity typeother

Related Parties

1
  • filerCIK 0001952158

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:39 PM ET
Size
39.4 KB